FiercePharma

FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder

As the United States' opioid epidemic rages on, health officials are busy looking for ways to help with the response. Now, right on the heels of the FDA's approval for a new overdose rescue medication ...
The Business Journals

Braeburn gets FDA approval for opioid use disorder drug after more than 4-year battle

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Brixadi, which was first ...
Fox 5 San Diego

BRIXADI® (buprenorphine) Extended-Release Injection for Subcutaneous Use (CIII) is Now Available in the U.S. for the Treatment of Moderate to Severe Opioid Use Disorder

BRIXADI is now available for healthcare settings and pharmacies through a restricted distribution program called the BRIXADI REMS and is administered only by a healthcare professional. PLYMOUTH ...
NPR

In Midst Of Opioid Crisis, FDA May Block New Addiction Drug From Market

More than 130 people in the U.S. die of an opioid overdose every day. One of the most effective ways to save lives is to get those struggling with addiction treated with medication to stop their ...